Clinical Applications of Immuno-PET in Lymphoma: A Systematic Review

Clinical Applications of Immuno-PET in Lymphoma: A Systematic Review

<b>Objective:</b> Immuno-positron emission tomography (iPET) combines the sensitivity of the PET imaging technique and the targeting specificity of radio-labelled monoclonal antibodies (mAb). Its first clinical applications in humans were described in the late 1990s, and several patholog...

Full description

Bibliographic Details
Main Authors:	Elizabeth Katherine Anna Triumbari, David Morland, Riccardo Laudicella, Matteo Bauckneht, Domenico Albano, Salvatore Annunziata
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Cancers
Subjects:	immuno-PET lymphoma systematic review human <sup>89</sup>Zr <sup>68</sup>Ga-pentixafor
Online Access:	https://www.mdpi.com/2072-6694/14/14/3488

Similar Items

<sup>68</sup>Ga-DOTATATE and <sup>68</sup>Ga-Pentixafor PET/CT in a Patient with Castleman Disease of the Retroperitoneum
by: Rui Zuo, et al.
Published: (2024-02-01)

[<sup>89</sup>Zr]-Atezolizumab-PET Imaging Reveals Longitudinal Alterations in PDL1 during Therapy in TNBC Preclinical Models
by: Adriana V. F. Massicano, et al.
Published: (2023-05-01)

<sup>89</sup>Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs
by: Iris H. C. Miedema, et al.
Published: (2023-11-01)

Imaging Inflammation in Atherosclerosis with CXCR4-Directed [<sup>68</sup>Ga]PentixaFor PET/MRI—Compared with [<sup>18</sup>F]FDG PET/MRI
by: Xia Lu, et al.
Published: (2022-07-01)

<sup>68</sup>Ga-Pentixafor PET/CT May Fail to Detect Recurrent Multiple Myeloma with Extramedullary Disease
by: Qingqing Pan, et al.
Published: (2023-02-01)

New Targets for PET Imaging of Myeloma
by: Mona-Elisabeth Revheim, et al.
Published: (2021-12-01)

CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas
by: Alexander Weich, et al.
Published: (2021-03-01)

Bing–Neel Syndrome and Coexisting Pituitary Macroadenoma in a Patient with Waldenström Macroglobulinemia Revealed by <sup>18</sup>F-FDG and <sup>68</sup>Ga-Pentixafor PET/CT
by: Qingqing Pan, et al.
Published: (2023-04-01)

[<sup>68</sup>Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with <sup>18</sup>F[FDG] PET Imaging
by: Ismaheel O. Lawal, et al.
Published: (2020-12-01)

Immuno-PET Imaging of Atherosclerotic Plaques with [<sup>89</sup>Zr]Zr-Anti-CD40 mAb—Proof of Concept
by: Kikkie Poels, et al.
Published: (2022-03-01)

Different Uptake of <sup>68</sup>Ga-FAPI and <sup>18</sup>F-FDG in Lymphadenopathy Caused by Angioimmunoblastic T-Cell Lymphoma in a Patient with Colon Cancer
by: Meiqi Wu, et al.
Published: (2022-09-01)

Radiopharmaceutical Labelling for Lung Ventilation/Perfusion PET/CT Imaging: A Review of Production and Optimization Processes for Clinical Use
by: Frédérique Blanc-Béguin, et al.
Published: (2022-04-01)

Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET
by: Xiaoyu Fan, et al.
Published: (2023-11-01)

CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [<sup>68</sup>Ga]Ga-Pentixafor in CRC Imaging
by: Katarína Benčurová, et al.
Published: (2022-11-01)

Preclinical Assessment Addressing Intravenous Administration of a [<sup>68</sup>Ga]Ga-PSMA-617 Microemulsion: Acute In Vivo Toxicity, Tolerability, PET Imaging, and Biodistribution
by: Vusani Mandiwana, et al.
Published: (2021-04-01)

Baseline <sup>18</sup>F-FDG PET/CT Radiomics in Classical Hodgkin’s Lymphoma: The Predictive Role of the Largest and the Hottest Lesions
by: Elizabeth Katherine Anna Triumbari, et al.
Published: (2023-04-01)

A Simple Kit for the Good-Manufacturing-Practice Production of [<sup>68</sup>Ga]Ga-EDTA
by: Monika Skulska, et al.
Published: (2023-08-01)

Preclinical PET and MR Evaluation of <sup>89</sup>Zr- and <sup>68</sup>Ga-Labeled Nanodiamonds in Mice over Different Time Scales
by: Gordon Winter, et al.
Published: (2022-12-01)

<sup>89</sup>Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo
by: Elahe Alizadeh, et al.
Published: (2021-02-01)

Wnt/β-Catenin Signaling Regulates CXCR4 Expression and [<sup>68</sup>Ga] Pentixafor Internalization in Neuroendocrine Tumor Cells
by: Alexander Weich, et al.
Published: (2021-02-01)

[<sup>68</sup>Ga]Ga-Pentixafor and Sodium [<sup>18</sup>F]Fluoride PET Can Non-Invasively Identify and Monitor the Dynamics of Orthodontic Tooth Movement in Mouse Model
by: Rogerio B. Craveiro, et al.
Published: (2022-09-01)

ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer
by: Ziqi Li, et al.
Published: (2023-03-01)

Analysis of Pros and Cons in Using [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer
by: Costantina Maisto, et al.
Published: (2022-06-01)

Head-to-Head Comparison of SSTR Antagonist [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>-LM4 with SSTR Agonist [<sup>68</sup>Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study
by: Rahul Viswanathan, et al.
Published: (2024-02-01)

Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors
by: Diletta Calabrò, et al.
Published: (2020-12-01)

Prevalence of Brain Incidental Lesions Detected by <sup>68</sup>Ga-DOTA Peptides PET/CT
by: Domenico Albano, et al.
Published: (2022-07-01)

Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with <sup>68</sup>Ga and <sup>177</sup>Lu as Potential Theranostic Agent for Colon Cancer
by: Radu Anton Leonte, et al.
Published: (2021-04-01)

[<sup>68</sup>Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [<sup>177</sup>Lu]DOTATOC PRRT: The “Theragnomics” Concept
by: Riccardo Laudicella, et al.
Published: (2022-02-01)

Re-Evaluations of Zr-DFO Complex Coordination Chemistry for the Estimation of Radiochemical Yields and Chelator-to-Antibody Ratios of <sup>89</sup>Zr Immune-PET Tracers
by: Ryota Imura, et al.
Published: (2021-08-01)

3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body <sup>18</sup>F-Fluorodeoxyglucose and <sup>89</sup>Zr-Rituximab PET Scans
by: Bart M. de Vries, et al.
Published: (2022-02-01)

<sup>68</sup>Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [<sup>68</sup>Ga]Ga-RM2
by: Adrien Chastel, et al.
Published: (2021-07-01)

Comparison of <sup>18</sup>F-FDG PET/CT and <sup>68</sup>Ga-FAPI in Spindle Cell Rhabdomyosarcoma
by: Zhihui Shen, et al.
Published: (2023-09-01)

Optimized <sup>68</sup>Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer
by: Yitian Wu, et al.
Published: (2022-08-01)

<sup>18</sup>F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?
by: Domenico Albano, et al.
Published: (2023-04-01)

In Vivo Fibroblast Activation of Systemic Sarcoidosis: A <sup>68</sup>Ga-FAPI-04 PET/CT Imaging Study
by: Jingnan Wang, et al.
Published: (2023-04-01)

<sup>18</sup>F-FDG PET Is Not Inferior to <sup>68</sup>Ga-PSMA PET for Detecting Biochemical Recurrent Prostate Cancer with a High Gleason Score: A Head-to-Head Comparison Study
by: Lian Xu, et al.
Published: (2023-12-01)

Imaging GRPr Expression in Metastatic Castration-Resistant Prostate Cancer with [<sup>68</sup>Ga]Ga-RM2—A Head-to-Head Pilot Comparison with [<sup>68</sup>Ga]Ga-PSMA-11
by: René Fernández, et al.
Published: (2023-12-01)

Head-to-Head Comparison between [<sup>68</sup>Ga]Ga-DOTA.SA.FAPi and [<sup>18</sup>F]F-FDG PET/CT Imaging in Patients with Breast Cancer
by: Sanjana Ballal, et al.
Published: (2023-03-01)

The Role of [<sup>68</sup>Ga]Ga-Pentixafor PET/CT or PET/MRI in Lymphoma: A Systematic Review
by: Domenico Albano, et al.
Published: (2022-08-01)

Evaluation of Predictors of Biochemical Recurrence in Prostate Cancer Patients, as Detected by <sup>68</sup>Ga-PSMA PET/CT
by: Mads T. Christensen, et al.
Published: (2022-01-01)